Tuesday, July 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Automotive & E-Mobility

BMW’s Preference Share Conversion and Index Expulsion Create Crosswinds for Beaten-Down Stock

Jackson Burston by Jackson Burston
July 7, 2026
in Automotive & E-Mobility, DAX, Dividends
0
BMW Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

BMW has reached two milestones that pull in opposite directions. The Munich-based automaker completed the conversion of roughly 55 million preference shares into common stock, eliminating its dual-class structure and boosting the free float. Yet simultaneously, the shares are being ejected from the S&P Europe 350 and FTSE All-World indices, forcing passive funds to sell. The stock changed hands at 60.84 euros on Wednesday, a gain of 0.93 percent on the day, but remains down roughly 36.6 percent year-to-date.

The conversion went through at a strict 1:1 ratio with no additional payment required from holders. The new common shares carry full dividend rights, retroactive to the start of 2026. The move simplifies BMW’s capital structure and increases the liquidity of the voting stock, but it comes at a moment when the company can ill afford additional headwinds.

The index expulsions add a mechanical layer of selling pressure on top of a deeply troubled fundamental picture. In mid-June, management slashed its annual targets, citing a sharp slowdown in China’s auto market, an intensifying price war there, and ongoing disruption from Middle East conflicts. The expected EBIT margin for the automotive segment was cut to a range of just one to three percent. The stock now trades roughly 26 percent below its 200-day moving average of 82.34 euros, and the 50-day average at 70.32 euros is also well above the current price. The relative strength index stands at 37, signaling an oversold condition, though no reversal pattern has yet emerged.

Should investors sell immediately? Or is it worth buying BMW?

Not all markets are suffering. Germany provided a bright spot last month, with BMW posting a nearly 20 percent increase in new registrations in June, outpacing both Audi and Mercedes. Over the first half of the year, BMW also overtook its Stuttgart rival in total registrations. On the product side, production of the updated 7-series began in early July at the Dingolfing plant, featuring improved batteries and a new display concept. Management has also reaffirmed its forecast for free cash flow of more than 2.5 billion euros in the auto segment, and the ongoing share buyback program and dividend payout ratio remain on track.

Analysts see value in the battered stock. LBBW recently raised its price target to 85 euros with a buy rating, while DZ Bank cut its fair value to 75 euros but maintained a buy recommendation. Both point to a price-to-earnings ratio of roughly seven as evidence that much of the bad news is already priced in. The caveat is the looming index-linked selling, which could weigh further in the short term.

Investors will get their next major update on July 10, when management holds a pre-close conference call on revenue trends. The full half-year report follows on July 30. That release, with detailed China sales figures and updated guidance, will be the key test of whether the stock can break its downward spiral or remain stuck near its 52-week low of 57.06 euros, a level touched only days ago on June 30.

Ad

BMW Stock: Buy or Sell?! New BMW Analysis from July 7 delivers the answer:

The latest BMW figures speak for themselves: Urgent action needed for BMW investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 7.

BMW: Buy or sell? Read more here...

Tags: BMW
Jackson Burston

Jackson Burston

Related Posts

Commerzbank Stock
Banking & Insurance

Commerzbank’s 1% Acceptance: How UniCredit Built a 40% Stake Without Most Shareholders’ Backing

July 7, 2026
Allianz Stock
Banking & Insurance

Allianz Pushes Into Energy Infrastructure as Buybacks Lift Stock to 52-Week High; Berenberg Sees 60% More Room

July 7, 2026
BMW Stock
Automotive & E-Mobility

BMW’s Motor Factory Ramp-Up Can’t Rev the Stock as Index Removal Compounds China Headwinds

July 7, 2026
Next Post
Novo Nordisk Stock

Novo Nordisk Expands Oral Wegovy to UK and New Liver Indication, Implant Study on Horizon

Recommended

Amneal Pharmaceuticals Reports Strong Financial Results for 2023 Sets Ambitious Goals for 2024

2 years ago
Strategy Stock

Bitcoin Strategy Firm Poised for Historic S&P 500 Inclusion

10 months ago
Finance_Commercial

Bread Financial Holdings Receives Upgrade and Price Target Stock Surges

2 years ago
Retail Market Capitalization

Analyst Community Bullish on Academy Sports After Investor Day Presentation

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Commerzbank’s 1% Acceptance: How UniCredit Built a 40% Stake Without Most Shareholders’ Backing

Nel ASA Shifts the Narrative from Climate to Security as a Cost Breakthrough Fails to Move the Needle

Allianz Pushes Into Energy Infrastructure as Buybacks Lift Stock to 52-Week High; Berenberg Sees 60% More Room

Institutional Skepticism vs. Sovereign Appetite: Gold’s Tug-of-War Intensifies Near $4,150

Diginex Names New Sales Chief as $1.5 Billion Resulticks Deal Enters Final Stretch

Navitas Semiconductor Loses Half Its Value as Dilution Fears Overwhelm GaN Growth Story

Trending

Novo Nordisk Stock
Analysis

Novo Nordisk Expands Oral Wegovy to UK and New Liver Indication, Implant Study on Horizon

by SiterGedge
July 7, 2026
0

Novo Nordisk is extending its oral Wegovy franchise across multiple fronts simultaneously, with a UK launch, a...

BMW Stock

BMW’s Preference Share Conversion and Index Expulsion Create Crosswinds for Beaten-Down Stock

July 7, 2026
FALLBACK Stock

From World Records to Spinal Implants: The New Arsenal Against Back Pain

July 7, 2026
Commerzbank Stock

Commerzbank’s 1% Acceptance: How UniCredit Built a 40% Stake Without Most Shareholders’ Backing

July 7, 2026
Nel ASA Stock

Nel ASA Shifts the Narrative from Climate to Security as a Cost Breakthrough Fails to Move the Needle

July 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Expands Oral Wegovy to UK and New Liver Indication, Implant Study on Horizon
  • BMW’s Preference Share Conversion and Index Expulsion Create Crosswinds for Beaten-Down Stock
  • From World Records to Spinal Implants: The New Arsenal Against Back Pain

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com